Zovane 20 Tablet contains Vilazodone 20mg, an antidepressant primarily indicated for the treatment of major depressive disorder (MDD) in adults. Vilazodone is a selective serotonin reuptake inhibitor (SSRI) and a partial agonist of the 5-HT1A receptor, which contributes to its antidepressant and anxiolytic effects by modulating serotonergic neurotransmission. This dual mechanism of action may result in improved efficacy and a faster onset of therapeutic benefits compared to traditional SSRIs. Zovane 20 is prescribed to alleviate symptoms of depression such as persistent sadness, loss of interest in daily activities, and impaired concentration. The medication should be administered orally, typically once daily with food to enhance absorption and reduce gastrointestinal side effects. Common adverse reactions include nausea, diarrhea, dizziness, and insomnia, which are generally mild and transient. Caution is advised in patients with a history of bipolar disorder, seizure disorders, or those taking other serotonergic agents due to the risk of serotonin syndrome. Zovane 20 should be used under medical supervision, with gradual dose adjustments as needed, and patients should be monitored for clinical improvement as well as any emergent suicidal ideation, especially during the initial treatment phase or dose changes.